Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin

Lung Cancer

Volumn 50, Issue 3, 2005, Pages 329-337

  Poulsen, Thomas T ^a   Pedersen, Nina ^a   Perin, Mark S ^b   Hansen, Celia K ^a   Poulsen, Hans S ^a  

^a FINSEN LABORATORY   (Denmark)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Neuronal pentraxin 1; Neuronal pentraxin 2; Neuronal pentraxin receptor; Small cell lung cancer; Taipan toxin; Taipoxin

Indexed keywords

PENTRAXIN; RECOMBINANT PROTEIN; SNAKE VENOM; TAIPOXIN; TOXIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; LUNG TOXICITY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; C-REACTIVE PROTEIN; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; DNA, NEOPLASM; ELAPID VENOMS; HUMANS; LUNG NEOPLASMS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 33644501790     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.06.011     Document Type: Article

References (26)

1. M.L. Janssen-Heijnen, and J.W. Coebergh Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe Lung Cancer 31 2001 123 137
2. M. Simon, A. Argiris, and J.R. Murren Progress in the therapy of small cell lung cancer Crit Rev Oncol Hematol 49 2004 119 133
3. A.F. Gazdar, L.J. Helman, M.A. Israel, E.K. Russell, R.I. Linnoila, and J.L. Mulshine Expression of neuroendocrine cell markers l-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin Cancer Res 48 1988 4078 4082
4. Y. Miyake, T. Kodama, and K. Yamaguchi Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma Cancer Res 54 1994 2136 2140
5. K. Rygaard, C. Moller, E. Bock, and M. Spang-Thomsen Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts Br J Cancer 65 1992 573 577
6. N. Pedersen, S. Mortensen, S.B. Sorensen, M.W. Pedersen, K. Rieneck, and L.F. Bovin Transcriptional gene expression profiling of small cell lung cancer cells Cancer Res 63 2003 1943 1953
7. D.C. Dodds, I.A. Omeis, S.J. Cushman, J.A. Helms, and M.S. Perin Neuronal pentraxin receptor, a novel putative integral membrane pentraxin that interacts with neuronal pentraxin 1 and 2 and taipoxin-associated calcium-binding protein 49 J Biol Chem 1997
8. M.B. Pepys, and M.L. Baltz Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein Adv Immunol 34 1983 141 212
9. D.M. Steel, and A.S. Whitehead The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein Immunol Today 15 1994 81 88
10. L.L. Kirkpatrick, M.M. Matzuk, D.C. Dodds, and M.S. Perin Biochemical interactions of the neuronal pentraxins: neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2 J Biol Chem 275 2000 17786 17792
11. A.K. Schlimgen, J.A. Helms, H. Vogel, and M.S. Perin Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system Neuron 14 1995 519 526
12. J. Fohlman, D. Eaker, E. Karlsson, and S. Thesleff Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the australian snake taipan (Oxyuranus s. scutellatus): isolation, characterization, quaternary structure and pharmacological properties Eur J Biochem 68 1976 457 469
13. J. Fohlman, D. Eaker, M.J. Dowdall, R. Lullmann-Rauch, T. Sjodin, and S. Leander Chemical modification of taipoxin and the consequences for phospholipase activity, pathophysiology, and inhibition of high-affinity choline uptake Eur J Biochem 94 1979 531 540
14. C. Montecucco, and O. Rossetto How do presynaptic PLA2 neurotoxins block nerve terminals? Trends Biochem Sci 25 2000 266 270
15. S.G. Cull-Candy, J. Fohlman, D. Gustavsson, R. Lullmann-Rauch, and S. Thesleff The effects of taipoxin and notexin on the function and fine structure of the murine neuromuscular junction Neuroscience 1 1976 175 180
16. P. Ñeco, O. Rossetto, A. Gil, C. Montecucco, and L.M. Gutierrez Taipoxin induces F-actin fragmentation and enhances release of catecholamines in bovine chromaffin cells J Neurochem 85 2003 329 337
17. J.B. Harris, and C.A. Maltin Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus Br J Pharmacol 76 1982 61 75
18. J.B. Harris, B.D. Grubb, C.A. Maltin, and R. Dixon The neurotoxicity of the venom phospholipases A(2), notexin and taipoxin Exp Neurol 161 2000 517 526
19. J.K. Blandino, M.P. Viglione, W.A. Bradley, H.K. Oie, and Y.I. Kim Voltage-dependent sodium channels in human small-cell lung cancer cells: role in action potentials and inhibition by Lambert-Eaton syndrome IgG J Membr Biol 143 1995 153 163
20. E. Sher, F. Giovannini, J. Boot, and B. Lang Peptide neurotoxins, small-cell lung carcinoma and neurological paraneoplastic syndromes Biochimie 82 2000 927 936
21. Y.C. Hsu, and M.S. Perin Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization Genomics 28 1995 220 227
22. F. Dreyer, and R. Penner The actions of presynaptic snake toxins on membrane currents of mouse motor nerve terminals J Physiol 386 1987 455 463
23. B.V. Lipps Isolation of subunits, alpha, beta and gamma of the complex taipoxin from the venom of Australian taipan snake (Oxyuranus s. scutellatus): characterization of beta taipoxin as a potent mitogen Toxicon 38 2000 1845 1854
24. J.N. Moreira, and R. Gaspar Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer Braz J Med Biol Res 37 2004 1185 1192
25. T.T. Poulsen, N. Pedersen, and H.S. Poulsen Replacement and suicide gene therapy for targeted treatment of lung cancer Clin Lung Cancer 6 2005 227 236
26. D.M. Nettelbeck, V. Jerome, and R. Muller Gene therapy: designer promoters for tumour targeting Trends Genet 16 2000 174 181